Lv4
490 积分 2026-03-30 加入
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
4小时前
待确认
Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma
16天前
已完结
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
19天前
已完结
Outcomes after CAR T Cells in Multiple Myeloma Patients with Extramedullary and Paramedullary Disease
5个月前
已关闭
Outcomes after CAR T Cells in Multiple Myeloma Patients with Extramedullary and Paramedullary Disease
5个月前
已关闭
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies
5个月前
已完结
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
5个月前
已完结
皖公网安备34019202002308
